We found that JMJD2A protein mainly localized in the nuclei and the positive rate in breast cancer tissues (93%, 144/155, Figure 1D (b)) was significantly higher than that in non-neoplastic tissues (3%, 1/30, Figure 1D (a)) (P <0.001). This evidence concerns the gene KDM4A and breast carcinoma.